BioSpace News Archive

Press Releases

NervGen Pharma Grants Stock Options

May 16, 2025
·
1 min read
Press Releases

Molecular Partners Reports Financial Results and Highlights from Q1 2025

May 16, 2025
·
12 min read
Press Releases

HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results

May 16, 2025
·
12 min read
Press Releases

InnoCare Announces First Patient Dosed in the Phase II/IIII Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Vitiligo in China

May 16, 2025
·
2 min read
Press Releases

Shape Therapeutics Presents Preclinical Data Highlighting Therapeutic Potential of RNA Editing and AAV Delivery Platforms at the American Society of Gene and Cell Therapy 28th Annual Meeting

May 16, 2025
·
4 min read
Press Releases

NanoViricides, Inc. Has Filed its Quarterly Report: Broad-Spectrum Antiviral NV-387 To Combat MPox Pandemic in Africa - Phase II Clinical Trial Update, Also Readying to Combat Measles Outbreaks, and to Tackle Bird Flu

May 16, 2025
·
16 min read
Press Releases

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - May 16, 2025

May 16, 2025
·
2 min read
Press Releases

Neurogene Announces Evidence-Based Monitoring and Treatment Intended to Reverse Rare Hyperinflammatory Syndrome Associated with High-Dose AAV

May 16, 2025
·
5 min read
Press Releases

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to a newly hired employee

May 16, 2025
·
2 min read
Press Releases

Pangea Laboratory Appoints John Moore as Chief Executive Officer

May 16, 2025
·
2 min read